Home › Trials › NCT06674863
Clinical trial Recruiting at 3 sites Interventional Ages 18 and up Men only

Tailored survivorship care plans to improve health literacy after prostate cancer

Official title: Addressing Health Literacy With a Tailored Survivorship Care Plan to Improve Access in Underserved African American Prostate Cancer Patients

Run by Emory University · NCT06674863 · Data updated 2026-11-12

This will test whether a survivorship care plan designed for people with low health literacy helps Black or African American men who finished treatment for localized or oligometastatic prostate cancer better understand and access follow-up care than a standard plan.

More Stage IVB Prostate Cancer AJCC v8 trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment150 (estimated)
SponsorEmory University
Academic / other
Drugs / interventionsradiation
Locations3 sites (Atlanta, Georgia and 2 other locations)
StatusRecruiting
StartedNovember 7, 2025
Main results expectedDecember 31, 2029
Study endsDecember 31, 2030
Registry record updatedSeptember 30, 2026
Trial IDNCT06674863 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Black or African American men who are disease-free 1–4 years after primary surgery and/or radiation for localized or oligometastatic prostate cancer, who can understand English and provide informed consent (patients on adjuvant non-palliative androgen deprivation therapy are eligible).

Probably not a fit

Patients with recurrent prostate cancer, active second malignancies requiring treatment, dementia or significant cognitive impairment, or who cannot clearly understand English are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study assigns eligible Black or African American men 1–4 years after primary surgery and/or radiation for localized or oligometastatic prostate cancer to receive either a standard survivorship care plan (SCP) or a tailored SCP plus a low-literacy educational supplement during a structured interview. Outcomes include patient-reported comprehension of survivorship recommendations, understanding of long-term and late treatment effects, and comparisons with provider assessments of patient health literacy. Participants complete standardized questionnaires and interviews over a 30–60 minute visit to measure differences between groups. The trial is conducted at Emory-affiliated sites in Atlanta and requires English proficiency and capacity to consent.

Why it matters

Potential benefit: If successful, the tailored SCP could improve patient understanding of follow-up care, increase engagement with recommended monitoring, and help reduce survivorship care disparities.

How similar studies have gone: Previous work using low-literacy educational materials and tailored survivorship communication has shown modest improvements in patient knowledge and self-management, but few trials have specifically targeted Black or African American prostate cancer survivors.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Black and African American men who are disease-free after completing primary surgery and/or radiation treatment for localized or oligometastatic prostate cancer between 1 to 4 years prior to enrollment. (Race/ethnicity per medical records and self report)
* Patients who are still receiving adjuvant androgen deprivation therapy following primary radiation with non-palliative intent may be included

Exclusion Criteria:

* Dementia or cognitive impairment per provider clinical assessment
* Unable to give informed consent in the judgement of the patient's oncology provider
* Recurrent prostate cancer after primary treatment
* Less than 18 years of age at the time of informed consent
* Diagnosis of active second malignancy requiring treatment
* Individuals who are not able to clearly understand English since the outcome measures require understanding of English

Where it's running

  • Grady Memorial Hospital
    Atlanta, Georgia, United States     Recruiting
  • Emory University Hospital/Winship Cancer Institute
    Atlanta, Georgia, United States     Recruiting
  • Atlanta VA Medical Center
    Atlanta, Georgia, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Localized Prostate Carcinoma 23Oligometastatic Prostate Carcinoma 3Stage IVB Prostate Cancer AJCC v8 28Emory University 2068
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.